Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET_Areceptor antagonist

By Tilton R.G.   Munsch C.L.   Sherwood S.J.   Chen S-J.   Chen Y-F.   Wu C.   Block N.   Dixon R.A.F.   Brock T.A.  

Pulmonary Pharmacology & Therapeutics, Vol. 13, Iss. 2, 2000-04 ,pp. : 87-97

Academic Press

Access to resources Recommend Favorite

Effects of Calcium Antagonist Felodipine on Renal Sympathetic Nerve Activity in Rats with Congestive Heart Failure

By Zhang Weiguo   Sun Xiangying   Zhao Xiaohe   Thorén Peter   Hedner Thomas  

Cardiovascular Drugs and Therapy, Vol. 11, Iss. 5, 1997-11 ,pp. : 645-650

Springer Publishing Company

Access to resources Recommend Favorite

Growth hormone, vascular reactivity, and heart failure

By Napoli Raffaele  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 1, 2006-02 ,pp. : 141-144

Springer Publishing Company

Access to resources Recommend Favorite

The Effect of the ET_A Receptor Antagonist (CI-1020) in Rats with Established Hypoxic Pulmonary Hypertension

By Sheedy W.   Haleen S.   Morice A.H.  

Pulmonary Pharmacology & Therapeutics, Vol. 11, Iss. 2, 1998-04 ,pp. : 173-176

Academic Press

Access to resources Recommend Favorite

Perindopril: In Congestive Heart Failure

By Simpson D.   Noble S.   Goa K.L.  

Drugs, Vol. 62, Iss. 9, 2002-01 ,pp. : 1367-1377

Adis International

Access to resources Recommend Favorite